establishing safety and care requirements for clinician-administered drugs.

Official Bill Page

Loading official bill page…

15 actions

May 14, 2026 lower

Refer for Interim Study: MA VV 05/14/2026 HJ 13
May 1, 2026 lower

Committee Report: Refer for Interim Study 04/29/2026 (Vote 15-0; CC) HC 19 P. 6
Apr 22, 2026 lower

Executive Session: 04/29/2026 10:00 am GP 229
Apr 16, 2026 lower

Subcommittee Work Session: 04/22/2026 10:00 am GP 229
Apr 2, 2026 lower

Public Hearing: 04/07/2026 02:15 pm GP 159
Apr 1, 2026 lower

Subcommittee Work Session: 04/08/2026 10:00 am GP 229
Mar 2, 2026 lower

Vacated and Referred to Commerce and Consumer Affairs (Rep. Kofalt): MA VV (in recess of) 02/19/2026 HJ 5 P. 127
Feb 26, 2026 lower

Introduced (in recess of) 02/19/2026 and referred to Health, Human Services and Elderly Affairs HJ 5 P. 124
Jan 7, 2026 upper

Ought to Pass with Amendment #2025-3029s, MA, VV; OT3rdg; 01/07/2026; SJ 1
Jan 7, 2026 upper

Committee Amendment # 2025-3029s, AA, VV; 01/07/2026; SJ 1
Oct 22, 2025 upper

Committee Report: Ought to Pass with Amendment # 2025-3029s, 01/07/2026; Vote 5-0; CC; SC 46
Mar 6, 2025 upper

Rereferred to Committee, MA, VV; 03/06/2025; SJ 6
Feb 21, 2025 upper

Committee Report: Rereferred to Committee, 03/06/2025; Vote 5-0; CC; SC 11
Feb 5, 2025 upper

Hearing: 02/12/2025, Room 101, LOB, 09:15 am; SC 9
Jan 23, 2025 upper

Introduced 01/09/2025 and Referred to Health and Human Services; SJ 3